What is psychedelic-assisted therapy and how does it work?

Psychedelic-assisted therapy is a clinical approach in which carefully structured sessions involving psychedelic substances — most commonly psilocybin, LSD, MDMA, or DMT — are embedded within a broader psychotherapeutic framework. The drug is not the treatment; it is, as Stanislav Grof put it, a catalyst. The therapeutic outcome depends far less on the pharmacology than on what surrounds it.

Grof's formulation from his decades of clinical work remains the clearest statement of the principle:

The drug itself is seen as a catalyst that activates the unconscious processes in a rather unspecific way. Whether the emergence of the unconscious material will be therapeutic or destructive is not determined simply by the biochemical and physiological action of LSD. It is a function of a number of non-drug variables, such as the personality structure of the subject, the relationship he or she has with the guide, sitter or persons present in the session, the nature and degree of specific psychological help, and the set and setting of the psychedelic experience.

"Set and setting" — the phrase Grof borrows from Humphrey Osmond — names two distinct variables. Set includes the subject's intentions, expectations, and motivations, along with the therapist's conceptual framework and the agreed-upon goals. Setting is the physical and interpersonal environment: the room, the music, the presence and quality of the guide. Grof illustrates the point with a knife: the same object is a surgical instrument, a murder weapon, or a kitchen tool depending entirely on who holds it and why. The same logic governs psychedelics. Discussions that appear to be about the dangers or benefits of LSD are almost always, on closer inspection, about different uses of the drug under different conditions.

What the drug does, neurologically and psychologically. Contemporary research has converged on default mode network (DMN) suppression as the key neurophysiological mechanism. The DMN is active during self-referential thought — the ongoing internal monologue, the maintenance of ego-identity. Mahr (2020) notes that suppressing the DMN correlates with the depersonalization, feelings of boundlessness, and dissolution of ego-boundaries that characterize the psychedelic state. Jung had a name for this loosening of the conscious personality's grip: abbaissement du niveau mental, a depotentiation of the ego's dominance. The ego, overwhelmed by imagery and an altered sense of personhood, must "give up" — and in that surrender, material that ordinarily remains dissociated becomes accessible.

This is where the depth-psychological reading becomes essential. The "trip ego," as Mahr observes, is structurally analogous to the dream ego: conscious but permeable, encountering figures and images from the deeper layers of the psyche. Archetypal material, shadow figures, trauma-laden images — these can appear with a numinosity and charge that ordinary waking consciousness rarely permits. Hall (1983) notes that the frequent experience of "being God" during psychedelic states is an encounter by the ego with its own archetypal core in the Self, but without the grounding necessary to establish a stable ego-Self axis — which is precisely why the therapeutic container matters so much.

The structure of treatment. Modern protocols, drawing on the research tradition Grof helped establish, require extensive preparation before the session and careful integration afterward. The guide's role is not passive: Grof argues that the therapist must have personal experience with the substance, because the extraordinary nature of psychedelic states cannot be understood from the outside. The transference relationship intensifies dramatically — projections that would take years to emerge in conventional therapy may appear within hours, and the guide may be experienced as ancestor, deity, or demon. This intensification is not a complication to be managed but a therapeutic opportunity, provided the guide has done sufficient inner work to hold it.

Von Franz (1993) offers a more cautionary reading from the same depth-psychological tradition. She observed that the unconscious itself reacts to drug-induced penetration of its sphere — that dreams following psychedelic use sometimes show the Self as angry, as a force that will not be circumvented without consequence. Her clinical vignettes suggest a spectrum: for some individuals, particularly those cut off from any access to the unconscious, a psychedelic experience may function as what Jung called "a heaven-sent gift without a counterpoison." For others, especially those who have already found a path inward through analysis, the drug may become illegitimate — the psyche itself withdrawing its cooperation.

What this means for the pneumatic question. It is worth naming what psychedelic-assisted therapy is most often asked to deliver: transcendence, unity, the dissolution of suffering in a flood of light. The research literature documents exactly this — the "oceanic boundlessness," the sense of cosmic connection, the post-session reports of meaning restored. These are real effects. They are also, in the diagnostic register, expressions of the pneumatic ratio: if I ascend far enough, I will not suffer. The clinical question — the one Grof's protocols implicitly address through integration work — is whether the experience lands in the soul or bypasses it. A well-guided session followed by rigorous integration may allow the material that surfaces to be metabolized rather than simply re-enchanted. A poorly guided session, or one without integration, risks what Kalsched (1996) warns of more broadly: the ego trivializing or defensively appropriating what it encountered, using a shallow spiritual experience to avoid the deeper confrontation.

The difference, as Mahr puts it in a clinical vignette, is between a voluntary journey and a kidnapping — and between a guide who welcomes the descent to the basement and one who keeps saying, "You don't need to go there."

  • Stanislav Grof — portrait of the founder of transpersonal psychology and pioneer of LSD-assisted psychotherapy
  • abbaissement du niveau mental — Jung's term for the depotentiation of conscious personality
  • active imagination — Jung's method for intentional engagement with unconscious material, structurally related to the guided psychedelic experience
  • Donald Kalsched — portrait of the analyst who mapped the archetypal defenses of the traumatized psyche

Sources Cited

  • Grof, Stanislav, 1980, LSD Psychotherapy: Exploring the Frontiers of the Hidden Mind
  • Mahr, Greg, 2020, Psychedelic Drugs and Jungian Therapy
  • Hall, James A., 1983, Jungian Dream Interpretation: A Handbook of Theory and Practice
  • von Franz, Marie-Louise, 1993, Psychotherapy
  • Kalsched, Donald, 1996, The Inner World of Trauma: Archetypal Defences of the Personal Spirit